Local drugmakers to face another government-mandated price cuts

Published: 2012-06-01 06:56:00

Updated: 2012-06-01 06:56:00

The Korean pharmaceutical industry will be hit with the second price cuts of drugs in the latter half of the year as several companies were found to pay illegal rebate to doctors last year.

In a recent lawsuit, the Seoul Administrative Court rejected the claims of Chong Kun Dang Pharma over th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK